Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-29T07:42:18.026Z Has data issue: false hasContentIssue false
  • English
  • Français

Can Topical and Nonabsorbable Antimicrobials Prevent Cross-Transmission of Resistant Strains in ICUs?

Published online by Cambridge University Press:  02 January 2015

Christian Brun-Buisson  and
Patrick Legrand
Christian Brun-Buisson*
Affiliation:
Department of Medical Intensive Care, Hôpital Henri Mondor and Université Paris-XII, Créteil, France
Patrick Legrand
Affiliation:
Department of Medical Microbiology, Hôpital Henri Mondor and Université Paris-XII, Créteil, France
*
Service de Réanimation Médicale, Hôpital Henri Mondor, 51 Ave Mal de Lattre de Tassigny, 94010, Créteil, France
Get access Rights & Permissions [Opens in a new window]

Abstract

Topical antimicrobials may complement traditional infection control measures and hasten the control of an outbreak. When a suitable nonabsorbable antimicrobial regimen can be found, its use during outbreaks caused by Enterobacteriaceae colonizing the digestive tract appears especially attractive, whether the infection occurs via primary endogenous colonization or exogenous colonization. In the latter circumstance, however, topical antimicrobials are not a substitute for isolation precautions and careful handwashing, which remain insufficiently adhered to in ICUs. Topical antimicrobials should be used as part of a global strategy in which isolation precautions remain of primary importance. It is likely, but unproven by well-designed studies, that nasal decontamination of patient carriers during outbreaks due to methicillin-resistant Staphylococcus aureus can be useful to control the outbreak. In this instance, however, skin and wound disinfection appears as an essential complementary measure, and careful attention should be given to extranasal sites of colonization with MRSA, where resistance to the topical agent can emerge. Whatever the circumstances and setting, prolonged use of topical antimicrobials during protracted outbreaks is less effective and carries a major risk of resistance to the topical agent(s) used against the outbreak strains. In such circumstances, careful microbiologic monitoring of colonization is mandatory.

Type
From the Third International Conference on the Prevention of Infection
Information
Infection Control & Hospital Epidemiology , Volume 15 , Issue 7 , July 1994 , pp. 447 - 455
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Feeley, TW, Du Moulin, GC, Hedley-Whyte, J, Bushnell, LS, Gilbert, JP, Feingold, DS. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975;293:471–475.Google Scholar
2.Clasener, HAL, Vollaard, EJ, VanSaene, HKF. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation. Rev Infect Dis 1987;9:295–328.Google Scholar
3.Stoutenbeek, CP, VanSaene, HFK, Miranda, DR, Zandstra, DEThe effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Intensive Care Med 1984;10:185–188.Google Scholar
4.Hamer, DH, Barza, M. Prevention of hospital-acquired pneumonia in critically ill patients. Antimicrob Agents Chemother 1993;37:931–938.Google Scholar
5.Pizzo, PAEmpirical therapy and prevention of infection in the immuno-compromised host. In: Mandell, GL, Douglas, RG, Bennett, JE, eds. Principles and Practice of Infectious Diseases. New York, NY: Churchill Livingstone; 1990:2303–2311.Google Scholar
6.Gastinne, H, Wolff, M, Delatour, F, Faurisson, F, Chevret, S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 1992;326:594–599.Google Scholar
7.Brun-Buisson, C. Selective digestive tract decontamination: interpreting the synthetized evidence. Chest 1994;104:978–980.Google Scholar
8.Schwartz, SN, Dowling, IN, Benkovic, C, DeQuinter-Buchanan, M, Protsko, T, Yee, RB. Sources of gram-negative bacilli colonizing the trachea of intubated patients. J Infect Dis 1978;138:227–231.Google Scholar
9.Goldmann, DA, Leclair, J, Macone, ABacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978;2:288–293.Google Scholar
10.Fainstein, V, Rodriguez, V, Turk, M, Hermann, G, Rosenbaum, B, Bodey, JP. Patterns of oropharyngeal and fecal flora in patients with acute leukemia. J Infect Dis 1981;144:10–18.Google Scholar
11.Flynn, DM, Weinstein, RA, Nathan, C, Gaston, MA, Kabins, SA. Patients' endogenous flora as the source of “nosocomial” Enterobacter in cardiac surgery. J Infect Dis 1987;156:363–368.Google Scholar
12.Chow, JW, Fine, MJ, Shlaes, DM, et al.Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585–590.Google Scholar
13.Olson, B, Weinstein, RA, Nathan, C, Chamberlin, W, Kabins, SA. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis 1984;150:808–816.Google Scholar
14.Selden, R, Lee, S, Wang, WLL, Bennett, TV, Eickoff, TC. Nosocomial Klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med 1971;74:657–664.Google Scholar
15.Schaberg, DR, Weinstein, RA, Stamm, WE. Epidemics of nosocomial urinary tract infection caused by multiply-resistant gram-negative bacilli: epidemiology and control. J Infect Dis 1976;133:363–366.Google Scholar
16.Graham, DR, Anderson, RL, Ariel, FE, et al.Epidemic nosocomial meningitis due to Citrobacter in neonates. /Infect Dis 1981;144:203–209.Google Scholar
17.Brun-Buisson, C. Legrand, P, Philippon, A, Montravers, F, Ansquer, M, Duval, J. Transferable enzymatic resistance to third generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302–306.Google Scholar
18.Markowitz, SM, Veazey, JM, Macrina, FL, Mayhall, CG, Lamb, VA. Sequential outbreaks of infection due to Klebsiella pneumoniae in a neonatal intensive care unit: implication of a conjugative R-plasmid. J Infect Dis 1980;142:106–112.Google Scholar
19.Weinstein, RA, Kabins, SA. Strategies for prevention and control of multiple drag-resistant nosocomial infection. Am J Med 1981;70:449–453.Google Scholar
20.Goldmann, DA. The role of barrier precautions in infection control. J Hosp Infect 1991;18(suppl 1):515–523.Google Scholar
21.Weinstein, RA. Epidemiolopgy and control of nosocomial infections in adult intensive care units. Am J Med 1991;91 (suppl 3B):179S–184S.Google Scholar
22.Casewell, MW, Philips, I. Hands as a route of transmission for Klebsiella species. Br Med J 1977;2:1315–1317.Google Scholar
23.Klein, BS, Perloff, WH, Maki, DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989;320:1714–1721.Google Scholar
24.Weinstein, RA, Nathan, C, Gruensfelder, R, Kabins, SA. Endemic aminogly-coside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis 1980;141:338–345.Google Scholar
25.Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309–317.Google Scholar
26.Shlaes, DM, Currie-McCumber, CA, Lehman, MH. Introduction of a encoding the OHIO-1 p-lactamase to an intermediate care ward by patient transfer. Infect Control Hosp Epidemiol 1988;9:317–319.Google Scholar
27.Kauffman, CA, ‘Tpenning, MS. Xiaogong, H, et al.Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am J Med 1993;94:371–378.Google Scholar
28.Rose, HD, Pendharker, MB, Snider, GL, Kory, RC. Evaluation of sodium colistimethate aerosol in gram-negative infections of the respiratory tract. J Clin Pharmacol 1970;10:274–281.Google Scholar
29.Klastersky, I, Huysmans, E, Weerts, D, Hensgens, C, Daneau, D. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 1974;35:650–654.Google Scholar
30.Klastersky, J, Hensgens, C, Noterman, J, Mouawad, E, Meunier-Carpentier, F. Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheostomized unconscious patients. A comparative study of gentamicin and aminosid-polymyxin B combination. Chest 1975;68:302–306.Google Scholar
31.Klastersky, J, Carpentier-Meunier, F, Kaan-Coppens, L, et al.Endotracheally administered antibiotics for gram-negative broncho-pneumonia. Chest 1979;75:586–591.Google Scholar
32.Johanson, WG, Seindenfeld, JJ. De LosSantos, R, Coalson, JJ, Gomez, P. Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Am Rev Respir Dis 1988;137:265–272.Google Scholar
33.Jarlier, V, Nicolas, MH, Fournier, G, Philippon, A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867–878.Google Scholar
34.De Champs, C, Rouby, D, Guelon, D. et al.A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991;18:5–13.Google Scholar
35.Coovadia, YM, Johnson, AP, Bhana, RH, Hutchinson, GR, George, RC. Hafferjee, IE. Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992;22:197–205.Google Scholar
36.Rasmussen, BA, Bradford, PA, Quinn, JP, Wiener, J, Weinstein, RA, Bush, K. Genetically diverse ceftazidime-resistant isolates from a single center: biochemicalandgenetic Characterization of TEM-10 β-lactamases encoded by different nucleotide sequence. Antimicrob Agents Chemother 1993;37:1989–1992.Google Scholar
37.Meyer, KS, Urban, C, Eagan, JA, Berger, BJ, Rahal, JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.Google Scholar
38.Freeman, J, McGowan, JE. Risk factors for nosocomial infections. J Infect Dis 1978;138:811–819.Google Scholar
39.Brun-Buisson, C, Legrand, P, Rauss, A, et al.Digestive tract decontamination to control nosocomial multiresistant gram-negative bacilli: study of an outbreak in an ICU. Ann Intern Med 1989;110:873–881.Google Scholar
40.Taylor, ME, Oppenheim, BA. Selective decontamination of the gastmintestinal tract as an infection control measure. J Hosp Infect 1991;17:271–278.Google Scholar
41.De Champs, CL, Guelon, DP, Garnier, RM, et al.Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit. Intensive Care Med 1993;19:191–196.Google Scholar
42.Calvat, S, Jolly, ML, Jourdain, B. Trouillet, JL, Chastre, J, Gibert, C. Digestive decontamination to reduce extended-spectrum p-lactamase producing Enterobacteriaceae colonization and infections in ICU patients. Presented at the 33rd International Conference on Antimicrobial Agents and Chemo therapy; October 17-20, 1993; New Orleans, Louisiana. Abstract 862.Google Scholar
43.Casewell, MW, Phillips, I. Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med 1981;70:459–462.Google Scholar
44.Brumtitt, W, Hamilton-Miller, J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188–1196.Google Scholar
45.Casewell, MW, Hill, RLR. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986;18(suppl A):1–12.Google Scholar
46.Sheagren, JN. Staphylococcus aureus: the persistent pathogen. N Engl J Med 1984;310:1368–1373.Google Scholar
47.Boyce, JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46–54.Google Scholar
48.Yu, VL, Goetz, A, Wagener, M, et al.Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antimicrobial prophylaxis. N Engl J Med 1986;315:91–96.Google Scholar
49.Locksley, RM, Cohen, ML, Quinn, TC, et al.Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission and evolution of nosocomial infection. Ann Intern Med 1982;97:317–324.Google Scholar
50.Peterson, L, Quick, J, Jensen, B. et al.Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates: resistance during ciprofloxacine plus rifampin therapy for colonization. Arch Intern Med 1990;150:2151–2155.Google Scholar
51.Sande, MA, Mandell, GL. Effect of rifampicin on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1975;7:294–297.Google Scholar
52.Smith, SM, Eng, RHK, Tecsoin-Tumang, F. Ciprofloxacin therapy for methicillin-resistant S aureus infections or colonization. Antimicrob Agents Chemother 1989;33:181–184.Google Scholar
53.Neu, HC. The use of mupirocin in controlling methicillin-resistant Staphylococcus aureas. Infect Control Hosp Epidemiol 1990;11:11–12.Google Scholar
54.Noble, WC, Rahman, M, Cookson, B, Phillips, I. Transferable mupirocin resistance. J Antimicrob Chemother 1988;22:771–772.Google Scholar
55.Cookson, B. Mupirocin resistance in staphylococci. J Antimicrob Chemother 1990;25:497–503.Google Scholar
56.Bolaert, JR, Desmedt, RA, DeBaere, YA, et al.The influence of calcium mupirocine ointment on the incidence of Staphylococcus aureus infection in haemodialysis patients. Nephrol Dial Transplant 1989;4:278–281.Google Scholar
57.Hill, RLR, Duckworth, GJ, Casewell, MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988;22:377–384.Google Scholar
58.Doebbeling, BN, Breneman, DL, Neu, HC. et al.Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993;17:466–474.Google Scholar
59.Coovadia, YM, Bhana, RH, Johnson, AP, Haffejee, I. Marples, RR. A laboratory-confirmed outbreak of rifampicin-methicillin resistant Staphylococcus aureus in a newborn nursery. J Hosp Infect 1989;14:303–312.Google Scholar
60.Gaynes, R, Marosok, R, Mowry-Haley, J, et al.Mediastinitis following coronary artery bypass surgery: a 3-year review. J Infect Dis 1991;163:117–121.Google Scholar
61.Rao, N, Jacobs, S, Joyce, L. Cost-effective eradication of an outbreak of methicillin-resitant Staphylococcus aureus in a community-teaching hospital. Infect Control Hosp Epidemiol 1988;9:255–260.Google Scholar
62.Dacre, J, Emmerson, AM, Jenner, EA. Gentamicin-methicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect 1986;7:130–136.Google Scholar
63.Darouiche, R, Wright, C, Hamil, R, Koza, M, Lewis, D, Markowski, J. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother 1991;35:1612–1615.Google Scholar
64.Walsh, TJ, Vlahov, D, Hansen, SL, et al.Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Conntol 1987;8:7–14.Google Scholar
65.Hospital Infection Society and British Society for Antimicrobial Therapy Working Party. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1990;16:351–377.Google Scholar
66.Rimland, D, Robertson, B. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbial 1986;24:137–138.Google Scholar
67.Coello, R, Jimenez, J, Garcia, M, et al.Prospective study of infection, colonization, and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbial Infect Dis 1994;13:74–81.Google Scholar
68.Gaspar, MC, Sanchez, P, Uribe, P, Coello, R, Arroyo, P, Cruzet, F. Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1993;24:237–238.Google Scholar
69.Brun-Buisson, C, Rauss, A, Legrand, P, et al. Traitement du portage nasal de S aureus par la mupirocine nasale et prkention des infections acquises en r&animation: &de multicentrique controllé. Mid Mal Infect. In press.Google Scholar
70.Cederna, JE, Terpening, MS, Ensberg, M, Bradley, SF, Kauffman, CA. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol 1990;11:13–16.Google Scholar
71.Wenzel, RP, Nettleman, MD, Jones, RN, Pfaller, MAMethicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991;9l(suppl 3B):221–227.Google Scholar
72.Mulligan, ME, Murray-Leisure, KA, Ribner, S, et al.Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology, with implications for prevention and management. Am J Med 1993;94:313–328.Google Scholar
73.VanSaene, JM, VanSaene, HKF, Stoutenbeek, CP, Lerk, CEInfluence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal. Stand J Infect Dis 1985;17:295–300.Google Scholar
74.Misset, B, Kitzis, MD, Mahe, P, et al.Bacteriological side effects of gut decontamination with polymyxin E, gentamicin, and amphotericin B. Infect Control Hosp Epidemiol 1993;14:62–64.Google Scholar
75.Webb, CH. Antibiotic resistance associated with selective decontamination of the digestive tract. J Hosp Infect 1992;22:1–5.Google Scholar
76.Layton, MC, Perez, M, Heald, P, Patterson, JE. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993; 14:369–375.Google Scholar
77.Brown, RB, Phillips, D, Barker, MJ, Pieczarka, R, Sands, M, Teres, D. Nosocomial respiratory infections with Flavobacterium meningosepticum and its susceptibility to ciprofloxacin. Presented at the 28th International Conference on Antimicrobial Agents and Chemotherapy; 1988; Los Angeles, California. Abstract A1080.Google Scholar
78.Humphreys, H, Winter, R, Pick, A. The effect of selective decontamination of the digestive tract on gastrointestinal enterococccal colonization in ITU patients. Intensive Care Med 1992;18:459–463.Google Scholar
79.Leclercq, R, Derlot, E, Duval, J, Courvalin, F! Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157–161.Google Scholar
80.Bonten, MJM, VanTiel, FH, VanderGeest, , Stobbeingh, EE, Gaillard, CA. Enterococcus faeculis pneumonia complicating topical antimicrobial prophylaxis. N Engl J Med 1993;328:209–210.Google Scholar
81.Manso, E, DeSio, G, Biavasco, F, Varaldo, PE, Samba, G, Maffei, C. Vancomycin-resistant enterococci. Lancet 1993;342:616–617.Google Scholar
82.Stoutenbeek, CP, VanSaene, HKF, Zandstra, DEThe effect of oral nonab sorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 1987;19:513–520.Google Scholar
83.Nardi, G, Valentinis, U, Proietti, A, et al.Epidemiological impact of prolonged systematic use of topical SDD on bacteriological colonization of the tracheobronchial tree and antibiotic resistance. Intensive Care Med 1993;19:273–278.Google Scholar
84.Gastinne, H, Wolff, M, Lachatre, G, Boiteau, R, Savy, FP. Antibiotic levels in bronchial tree and in serum during selective digestive decontamination. Intensive Care Med 1991;17:215–218.Google Scholar
85.Albert, RK, Condie, F. Hand-washing patterns in medical intensive care units. N Engl J Med 1981;304:1465–1466.Google Scholar
86.Arnow, PM, Allyn, PA, Nichols, EM, Hill, DL, Pezzlo, M, Bartlett, RH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 1982;22:954–959.Google Scholar
87.Guiguet, M, Rekacewicz, C, Leclercq, B, Brun, Y, Escudier, B. Andremont, A. Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care. Infect Control Hosp Epidemiol 1990;11:23–26.Google Scholar